Table 1.
Demographic and clinical data (means ± standard deviation), before (pre) and after (post) treatment for schizophrenia patients per treatment group (n = 19 per group) together with statistical differences.
| Gender (m/f) | Age | Years of education | IQ | LQ | CPZ pre | CPZ post | |
|---|---|---|---|---|---|---|---|
| FAT | 11/8 | 39.6 ± 7.9 | 11.5 ± 1.7 | 108.1 ± 16.3 | 70.7 ± 59.0 | 617.2 ± 327.1 | 539.6 ± 289.2 |
| CE | 12/7 | 36.0 ± 8.5 | 10.8 ± 1.7 | 102.3 ± 13.6 | 60.7 ± 59.1 | 544.6 ± 490.1 | 506.1 ± 344.3 |
| TAU | 15/4 | 35.9 ± 10.6 | 11.3 ± 1.8 | 108.7 ± 17.4 | 59.0 ± 67.5 | 646.2 ± 393.9 | 637.9 ± 280.9 |
| Statistical difference | Chi2 = 2.0 n.s. | F2,54 = 1.04 n.s. | F2,50 < 1 n.s. | F2,54 < 1 | F2,54 < 1 | F2,53 < 1 | F2,50 < 1 |
| PANSS-P |
PANSS-N |
PANSS-G |
GAF |
|||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
| FAT | 16.1 ± 5.2 | 14.4 ± 4.6 | 19.2 ± 6.6 | 17.9 ± 6.2 | 36.9 ± 8.4 | 33.2 ± 8.2 | 42.5 ± 12.4 | 46.3 ± 13.4 |
| CE | 15.6 ± 5.2 | 12.6 ± 4.2 | 18.0 ± 6.5 | 17.4 ± 6.8 | 35.4 ± 5.5 | 30.5 ± 7.1 | 44.7 ± 13.6 | 50.1 ± 13.5 |
| TAU | 14.7 ± 4.9 | 13.6 ± 6.0 | 19.6 ± 6.1 | 18.3 ± 6.2 | 35.1 ± 9.0 | 34.3 ± 9.9 | 41.2 ± 13.4 | 43.0 ± 12.2 |
| Statistical difference | F2,54 < 1 | F2,53 < 1 | F2,54 < 1 | F2,52 < 1 | F2,54 < 1 | F2,53 = 1.0 n.s. | F2,54 < 1 | F2,53 = 1.4 n.s. |
Note: FAT: facial affect training, CE: cognitive exercise, TAU: treatment as usual; LQ: laterality quotient; CPZ: chlorpromazine equivalents; PANSS: Positive and Negative Symptom Scale (26); GAF: Global Assessment of Functioning (DSM-IV axis V); pre: before intervention onset; post: after 4-week intervention period; n.s.: p > .1.